• Developing PKC epsilon inhibitors to reduce chronic pain and alcohol consumption.
• Transcriptional profiling to repurpose drugs for treating substance use disorders.
• Identifying drug targets within neuroimmune pathways activated by chronic alcohol exposure.

Click to enlarge